Michael P. DiGiovanna

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Gϋnter von Minckwitz, Chiun‐Sheng Huang, Max S. Mano et al. · New England Journal of Medicine · 2018 · 2.6K citations · Full text

Medicine, Oncology, Pharmacology +17

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

Nancy U. Lin, Virginia F. Borges, Carey K. Anders et al. · Journal of Clinical Oncology · 2020 · 549 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Impact of Financial Burden of Cancer on Survivors' Quality of Life

Kathleen Fenn, Suzanne B. Evans, Ruth McCorkle et al. · Journal of Oncology Practice · 2014 · 473 citations

Medicine, Oncology, Cancer Epidemiology +16

Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States

Sarah S. Mougalian, Pamela R. Soulos, Brigid K. Killelea et al. · Cancer · 2015 · 246 citations · Full text

Medicine, Oncology, Breast Oncology +10

Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast Cancers

Syed K. Mohsin, Heidi L. Weiss, Maya Gutierrez et al. · Journal of Clinical Oncology · 2005 · 244 citations · Full text

Medicine, Oncology, Pharmacology +14